Literature DB >> 9827918

Bioactive substances in buffy-coat-derived platelet pools stored in platelet-additive solutions.

L Edvardsen1, E Taaning, T Mynster, J Hvolris, O Drachman, H J Nielsen.   

Abstract

We studied extracellular accumulation in buffy-coat-derived platelet pools suspended in platelet additive solutions (PAS). 20 platelet pools were prepared from buffy coats of 60 donors and stored in either PAS I (n = 10) or PAS II (n = 10). Samples were drawn from the donors to determine the normal range of histamine, plasminogen activator inhibitor 1 (PAI-1), myeloperoxidase (MPO) and interleukin (IL)-6. After preparation samples were collected on days 0, 5 and 7 from the 20 platelet pools respectively, to determine extracellular accumulation of the same substances. Extracellular histamine, PAI-1 and MPO were detected in significant levels (P<0.0001) immediately after preparation of the platelet pools. Only the extracellular level of PAI-1 increased significantly during storage from day 0 to day 7 (P<0.01). After preparation and storage to day 7 IL-6 was found in only three of the 20 platelet pools. Even though platelets were prepared by the buffy-coat method, to produce a low leucocyte count and thereby low cytokine (IL-6) content, there was still significant contamination by other bioactive substances.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9827918     DOI: 10.1046/j.1365-2141.1998.00990.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  A Comparative Assessment of Quality of Platelet Concentrates Prepared by Buffy Coat Poor Platelet Concentrate Method and Apheresis Derived Platelet Concentrate Method.

Authors:  R S Mallhi; Sudeep Kumar; Joseph Philip
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-03       Impact factor: 0.900

2.  The IgE-dependent pathway in allergic transfusion reactions: involvement of donor blood allergens other than plasma proteins.

Authors:  Nobuki Matsuyama; Kazuta Yasui; Etsuko Amakishi; Tomoya Hayashi; Ayumu Kuroishi; Hiroyuki Ishii; Harumichi Matsukura; Yoshihiko Tani; Rika A Furuta; Fumiya Hirayama
Journal:  Int J Hematol       Date:  2015-04-04       Impact factor: 2.490

3.  Leukoreduced blood components: Advantages and strategies for its implementation in developing countries.

Authors:  R R Sharma; Neelam Marwaha
Journal:  Asian J Transfus Sci       Date:  2010-01

4.  A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440].

Authors:  Neil Blumberg; Joanna M Heal; Jacob M Rowe
Journal:  BMC Blood Disord       Date:  2004-12-10

Review 5.  Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment.

Authors:  Fumiya Hirayama
Journal:  Br J Haematol       Date:  2012-12-06       Impact factor: 6.998

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.